Ann Clin Microbiol Antimicrob. 2003 Mar 07;2:5. doi: 10.1186/1476-0711-2-5.
Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital.
Annals of clinical microbiology and antimicrobials
Ugur Gonlugur, Mustafa Zahir Bakici, Levent Ozdemir, Ibrahim Akkurt, Serhat Icagasioglu, Fusun Gultekin
PMID: 12665428
PMCID: PMC152644 DOI: 10.1186/1476-0711-2-5
Abstract
BACKGROUND: Lower respiratory tract infections due to Pseudomonas aeruginosa have a high mortality rate. Antibacterial activity of various antibiotics against P. aeruginosa isolated from each hospital depends on the variety or amount of antibiotics used in each hospital.
METHOD: A total of 249 respiratory isolates of Pseudomonas aeruginosa in Sivas (Turkey) were included between January-1999 and January-2002. Isolates were tested against 14 different antibiotics by a disc diffusion method or standardized microdilution technique.
RESULTS: Organisms were cultured from the following specimens: sputum (31.3%), transtracheal/endotracheal aspirates (37.8%), and bronchial lavage (30.9%). Isolates in bronchial lavage were highly susceptible to cefoperazone and aminoglycosides. Resistance to ampicillin/sulbactam was 98.8%, ticarcillin 40.1%, ticarcillin/clavulanic acid 11.2%, piperacillin 21.8%, aztreonam 66.6%, cefotaxim 75.4%, ceftriaxone 84.2%, cefoperazone 39.0%, ceftazidime 50.8%, gentamicin 57.5%, tobramycin 58.4%, amikacin 25.4%, ciprofloxacin 16.1%, and imipenem/cilastatin 21.6%. The term multidrug-resistant P. aeruginosa covered resistance to imipenem, ciprofloxacin, ceftazidime, gentamicin, and piperacillin. 1.2% of isolates were multidrug-resistant.
CONCLUSIONS: These findings suggest that amikacin resistance increases progressively in Turkey. Piperacillin and ticarcillin/clavulanate were the most active agents against both imipenem- and ciprofloxacin-resistant isolates in our region.
References
- Am J Med. 1986 Jun 30;80(6B):76-81 - PubMed
- Scand J Infect Dis. 1988;20(2):199-203 - PubMed
- Infect Control Hosp Epidemiol. 1992 Jan;13(1):10-4 - PubMed
- J Antimicrob Chemother. 1996 Feb;37(2):295-301 - PubMed
- Semin Respir Infect. 2000 Dec;15(4):287-98 - PubMed
- J Antimicrob Chemother. 1998 Feb;41(2):307-10 - PubMed
- Antimicrob Agents Chemother. 1999 Apr;43(4):981-2 - PubMed
- Chest. 2001 Feb;119(2 Suppl):397S-404S - PubMed
- Diagn Microbiol Infect Dis. 1998 Jan;30(1):53-9 - PubMed
Publication Types